A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...

PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research ...

An AI-powered biomarker based on histology alone predicted survival among men with metastatic hormone-sensitive prostate cancer and identified those who benefitted from escalation to triplet therapy.

Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...

Cornell silica nanoparticles eliminated prostate tumors in mice by triggering ferroptosis and activating immune response, ...

Orgovyx (relugolix) is a medicine used to treat advanced prostate cancer in adults. Advanced prostate cancer means that the cancer has spread outside of the prostate. Advanced cancers have often come ...

Prostate cancer is a common form of cancer that affects males. The CyberKnife is a device that uses radiation therapy that can help treat prostate cancer. CyberKnife is the brand name for a system of ...

For many men with prostate cancer, the word “radiotherapy” still conjures up weeks of daily hospital trips: 20 or more sessions, Monday to Friday, for a month or longer. A new NHS England programme ...